B. Bubeck

发表

Residual Thallium Activity in Persistent Defects after Tracer Reinjection at Rest: A Marker of Myocardial Viability

S. Hagl, J. Zehelein, H. Tillmanns, 1995 .

Report of the Radionuclides in Nephrourology Committee for evaluation of transplanted kidney (review of techniques).

A. Taylor, G. Sfakianakis, C. Russell, 1999, Seminars in nuclear medicine.

The tubular extraction rate (TER) of ^ Tc-MAG3: A new quantitative parameter of renal function

B. Bubeck, 1987 .

Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study

F. Neumann, W. Kübler, B. Rauch, 2004, European Journal of Nuclear Medicine.

Renal function studies using 99mTc-MAG3: pharmacokinetics and slope clearance determination.

W. Brandau, S. Pomer, B. Bubeck, 1990, Contributions to nephrology.

Recurrent mediastinal mass in a child with Hodgkin's disease following successful therapy: a diagnostic challenge

U. Schmid, H. P. Wagner, B. Bubeck, 2005, Pediatric Surgery International.

Pharmacokinetics of Technetium-9 9m-MAG3 in Humans

Niranjan, W. Brandau, B. Bubeck, 2006 .

Melanoma affine radiopharmaceuticals

M. Eisenhut, B. Bubeck, K. zum Winkel, 1981, European Journal of Nuclear Medicine.

Pharmacokinetics of iodine-123-IMBA for melanoma imaging.

M. Eisenhut, W. Hull, B. Bubeck, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Melanoma affine radiopharmaceuticals I. A comparative study of 131I-labeled quinoline and tyrosine derivatives.

M. Eisenhut, B. Bubeck, K. zum Winkel, 1981, European journal of nuclear medicine.

Pharmacokinetics of technetium-99m-MAG3 in humans.

T. Kälble, W. Brandau, B Bubeck, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

I-123 PHIPA scintigraphy in chronic coronary artery disease: A comparative study with TL-201

M. Eisenhut, J. Hoffend, J. Zehelein, 1995 .

Report of the Radionuclides in Nephrourology Committee on renal clearance.

M D Blaufox, M. Blaufox, A. Taylor, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A new principle to normalize plasma concentrations allowing single-sample clearance determinations in both children and adults

B. Bubeck, K. Hahn, B. Ehrig, 2004, European Journal of Nuclear Medicine.

Renal clearance determination with one blood sample: improved accuracy and universal applicability by a new calculation principle.

B. Bubeck, 1993, Seminars in nuclear medicine.

Results of liver angiography and perfusion scintigraphy do not correlate with response to hepatic artery infusion chemotherapy

B. Lehner, B. Bubeck, U. Kretzschmar, 1988, Journal of surgical oncology.

Technetium-99m labeled renal function and imaging agents: III. Synthesis of 99mTc-MAG3 and biodistribution of by-products.

W. Brandau, D. Taylor, M. Eisenhut, 1988, International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes.

Technetium-99m labeled renal function and imaging agents: I. Clinical evaluation of 99mTc CO2-DADS-A (99mTc N,N'-bis-(mercaptoacetyl)-2,3-diaminopropanoate).

W. Brandau, M. Eisenhut, F. Reinbold, 1988, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Absorption of vitamin B12 administered to continent ileal reservoirs for urinary diversion.

G. Riedasch, G. Staehler, B. Bubeck, 1996, Urologia internationalis.

99mTc-MAG3: chemistry and biokinetics of by-products.

O. Schober, W. Brandau, D. Taylor, 1990, Contributions to nephrology.

Non-Invasive Detection of Reduced Regional Myocardial Perfusion at Rest in Patients with Unstable Angina Pectoris: Increased Regional 81mKr Deposition following Intravenous Injection of 81 Rb

W. Kübler, F. Neumann, H. Bihl, 1991, Nuklearmedizin.

Residual 201Tl activity in irreversible defects as a marker of myocardial viability. Clinicopathological study.

S. Hagl, W. Kübler, B. Rauch, 1995, Circulation.

Hydroxylation of quinaldic acid: quinaldic acid 4-monooxygenase from Alcaligenes sp. F-2 versus quinaldic acid 4-oxidoreductases.

S. Fetzner, F. Lingens, B. Tshisuaka, 1996, Biochimica et biophysica acta.

Benzodiazepine receptor distribution and diazepam binding in schizophrenia: an exploratory study

H. Sauer, J. Schröder, B. Bubeck, 1997, Psychiatry Research: Neuroimaging.

Labeling of iodine 131 labeled m iodobenzylguanidine with high specific activity for radiotherapeutical purposes

B. Kimmig, M. Eisenhut, B. Bubeck, 1984 .

Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study

H. Sauer, J. Schröder, B. Bubeck, 1997, Psychiatry Research: Neuroimaging.

TECHNETIUM-99M LABELED RENAL FUNCTIONING AND IMAGING AGENTS. II: CLINICAL EVALUATION OF TC-99M-MAG3

W. Brandau, M. Eisenhut, F. Reinbold, 1988 .

Therapeutic impact of 2-[fluorine-18]fluoro-2-deoxy-D-glucose positron emission tomography in the pre- and postoperative staging of patients with clinically intermediate or high-risk breast cancer.

A. Mueller, B. Klaeser, D. Koeberle, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

D2 Dopamine Receptor Up-Regulation, Treatment Response, Neurological Soft Signs, and Extrapyramidal Side Effects in Schizophrenia: A Follow-Up Study with 123I-Iodobenzamide Single Photon Emission Computed Tomography in the Drug-Naive State and after Neuroleptic Treatment

H. Sauer, J. Schröder, F. Geider, 1998, Biological Psychiatry.

Scintigraphy of a neuroblastoma with I-131 meta-iodobenzylguanidine.

B. Kimmig, M. Eisenhut, H. Hermann, 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A New Methodical Approach for the Imaging of Cerebral Benzodiazepine Receptors in Schizophrenia: Preliminary Results of a Single Photon Emission Tomography Study with [123I] Iomazenil

H. Sauer, J. Schröder, U. Roelcke, 1993 .